Colgate-Palmolive Payments for Repurchase of Common Stock decreased by 24.6% to $306.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.7%, from $284.00M to $306.00M. Over 4 years (FY 2021 to FY 2025), Payments for Repurchase of Common Stock shows relatively stable performance with a -2.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Higher spending indicates a commitment to returning capital to shareholders or offsetting dilution from stock-based compensation.
The cash outflow associated with the company's repurchase of its own common shares from the open market. This is a prima...
Standard capital return metric for mature public companies.
other_payments_for_repurchase_of_common_stock| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $341.00M | $251.00M | $356.00M | $410.00M | $381.00M | $104.00M | $413.00M | $180.00M | $371.00M | $332.00M | $245.00M | $509.00M | $480.00M | $295.00M | $455.00M | $284.00M | $232.00M | $288.00M | $406.00M | $306.00M |
| QoQ Change | — | -26.4% | +41.8% | +15.2% | -7.1% | -72.7% | +297.1% | -56.4% | +106.1% | -10.5% | -26.2% | +107.8% | -5.7% | -38.5% | +54.2% | -37.6% | -18.3% | +24.1% | +41.0% | -24.6% |
| YoY Change | — | — | — | — | +11.7% | -58.6% | +16.0% | -56.1% | -2.6% | +219.2% | -40.7% | +182.8% | +29.4% | -11.1% | +85.7% | -44.2% | -51.7% | -2.4% | -10.8% | +7.7% |